To investigate the presence and potential pathophysiological role of e
ndogenous retroviruses in humans, we prepared a recombinant protein us
ing clone 4-1, a proviral sequence. DNA fragments containing the env r
egion of clone 4-1 were subcloned into a prokaryotic expression vector
(pET3), and 2 fusion proteins, SU413 and SU415, were then expressed i
n Escherichia coli after treatment with isopropyl-beta-thiogalactopyra
noside (IPTG). By sonicating lysates of the transformed E. coli, the r
ecombinant protein SU413 was successfully separated from the native ba
cterial components, and was used to raise an antiserum in rabbits. In
immunoblot analysis, this antiserum specifically recognized the recomb
inant protein, but did not react with other components of E. coli. Thi
s antiserum was then used for an immunofluorescence study of human pla
centa, in which the env gene transcript has been reported. As a result
, the anti-SU413 serum detected substance sin syncytiotrophoblasts and
vascular endothelia from a human placenta. No such reactivity was det
ected in human kidney or human liver. Immunoblot analysis revealed tha
t this antiserum reacted to a single molecule of 38-kDa in placenta, a
nd its reactivity was reduced by the antiserum absorbed with SU413 ant
igen. These findings suggest that human placental syncytiotrophoblasts
and vascular endothelia preferentially express a molecule encoded by
human endogenous retrovirus clone 4-1. (C) 1994 Wiley-Liss, Inc.